Curcumin analog L3 alleviates diabetic atherosclerosis by multiple effects

European Journal of Pharmacology

Volumn 775, Issue , 2016, Pages 22-34

  Zheng, Bin ^a,b   Yang, Liu ^a,b   Wen, Caixia ^a,b   Huang, Xiuwang ^a,b   Xu, Chenxia ^a,b   Lee, Kuan Han ^c   Xu, Jianhua ^a,b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Fujian Provincial Key Laboratory of Natural Medicine Pharmacology   (China)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Analog ofcurcumin; Diabetic atherosclerosis; Dyslipidemia; Hyperglycemia; L3

Indexed keywords

ANTIDIABETIC AGENT; CATALASE; CURCUMIN; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDUCIBLE NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROBUCOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; [1,7 BIS(3,5 DI TERT BUTYL 4 HYDROXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE]; ANTILIPEMIC AGENT; OLR1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA ARCH; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CURCUMA LONGA; DIABETIC ATHEROSCLEROSIS; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DYSLIPIDEMIA; ENZYME ACTIVITY; GLUCOSE METABOLISM; HYPERGLYCEMIA; KIDNEY MASS; LIPID METABOLISM; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; AORTA; BLOOD; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; HYPERLIPIDEMIAS; LIPID DIET; LIVER; METABOLISM; PANCREAS; PATHOLOGY;

ANIMALS; AORTA; ATHEROSCLEROSIS; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIVER; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PANCREAS; REACTIVE OXYGEN SPECIES; SCAVENGER RECEPTORS, CLASS E;

EID: 84959510307     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.02.016     Document Type: Article

References (21)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 37 Suppl. 1 2014 S81 S90
2. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
3. J.M. Chehade, M. Gladysz, and A.D. Mooradian Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management Drugs 73 2013 327 339
4. D.J. Chiang, M.T. Pritchard, and L.E. Nagy Obesity, diabetes mellitus, and liver fibrosis Am. J. Physiol. Gastrointest. Liver Physiol. 300 2011 G697 G702
5. B. Halliwell Free radicals, antioxidants, and Human disease: curiosity, cause, OR consequence? Lancet 344 1994 721 724
6. M. Kaplan, M. Aviram, and T. Hayek Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: role of insulin therapy Pharm. Ther. 136 2012 175 185
7. T. Kita, N. Kume, M. Minami, K. Hayashida, T. Murayama, H. Sano, H. Moriwaki, H. Kataoka, E. Nishi, H. Horiuchi, H. Arai, and M. Yokode Role of oxidized LDL in atherosclerosis Ann. NY Acad. Sci. 947 2001 199 205 (discussion 205-196)
8. R.M. Krauss Lipids and lipoproteins in patients with type 2 diabetes Diabetes Care 27 2004 1496 1504
9. M. Kuroda, Y. Mimaki, T. Nishiyama, T. Mae, H. Kishida, M. Tsukagawa, K. Takahashi, T. Kawada, K. Nakagawa, and M. Kitahara Hypoglycemic effects of turmeric (curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice Biol. Pharm. Bull. 28 2005 937 939
10. Y. Liu, b Zheng, X. Xu, and J. Xu Effect of Curcumin derivatives on glucose tolerance and lipid metabolism in diabetic mice J. Fujian Med. Univ. 44 2010 168 171
11. B. Meng, J. Li, and H. Cao Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications Curr. Pharm. Des. 19 2013 2101 2113
12. S.F. Nabavi, R. Thiagarajan, L. Rastrelli, M. Daglia, E. Sobarzo-Sanchez, H. Alinezhad, and S.M. Nabavi Curcumin: a natural product for diabetes and its complications Curr. Top. Med. Chem. 15 2015 2445 2455
13. K.L. Ong, A.W. Tso, K.S. Lam, S.S. Cherny, P.C. Sham, and B.M. Cheung Using glycosylated hemoglobin to define the metabolic syndrome in United States adults Diabetes Care 33 2010 1856 1858
14. L.X. Qiu, and T. Chen Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease World J. Gastroenterol. 21 2015 1099 1107
15. L. Rochette, M. Zeller, Y. Cottin, and C. Vergely Diabetes, oxidative stress and therapeutic strategies Biochim. Biophys. Acta 1840 2014 2709 2729
16. G.B. Sajithlal, P. Chithra, and G. Chandrakasan Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats Biochem. Pharm. 56 1998 1607 1614
17. B. Stefanska Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus - insights into its mechanisms of action Br. J. Pharm. 166 2012 2209 2211
18. G.R. Steinberg, and J.D. Schertzer AMPK promotes macrophage fatty acid oxidative metabolism to mitigate inflammation: implications for diabetes and cardiovascular disease Immunol. Cell Biol. 92 2014 340 345
19. P. Venkatesan, and M.N. Rao Structure-activity relationships for the inhibition of lipid peroxidation and the scavenging of free radicals by synthetic symmetrical curcumin analogues J. Pharm. Pharm. 52 2000 1123 1128
20. E. Xiao, and D.T. Graves Impact of diabetes on the protective role of FOXO1 in wound healing J. Dent. Res. 94 2015 1025 1026
21. H. Zhu, X. Jin, J. Zhao, Z. Dong, X. Ma, F. Xu, W. Huang, G. Liu, Y. Zou, K. Wang, K. Hu, A. Sun, and J. Ge Probucol protects against atherosclerosis through Lipid-lowering and suppressing immune maturation of CD11c+dendritic cells in STZ-induced diabetic LDLR-/- mice J. Cardiovasc. Pharm. 65 2015 620 627